Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. (Q46612829)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 April 2017

Language	Label	Description	Also known as
English	Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.	scientific article published on 14 April 2017

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Robert H Collins

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

William Blum

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Patrick S Stiff

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Laurence Elias

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jane S Lebkowski

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Anita Reddy

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Kevin P Nishimoto

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Edward D Wirth

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Casey C Case

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

John F DiPersio

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

0 references

publication date

14 April 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

123

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

3061-3072

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Drug therapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: novel agents and approaches currently in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Telomerase and human tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

RNA-transfected dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

How the immune system achieves self-nonself discrimination during adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

21 January 2018

Immunotherapy of hematologic malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

7 January 2021

based on heuristic

inferred from DOI database lookup

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.30696

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.30696

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28411378%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46612829&oldid=1790345995"